GLP-1 RECEPTOR AGONIST

The present invention relates to a compound represented by Formula 1 wherein A, B, L, X, and R1 to R6 are as described herein, or a pharmaceutically acceptable salt thereof, which serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of a disease associated with GLP-1 a...

Full description

Saved in:
Bibliographic Details
Main Authors HWANG, Jeong-Un, KIM, Dae Hoon, BAEK, Myoung Ki, KANG, Seung-Tae, LEE, Kyu-Hwan, YOON, Hyun-Ho, LA, Hyun-Hwa, JANG, Jung-In, KIM, Jin Woong, HA, Neul, LEE, Han Kyu, CHOI, Hyung-Ho, LEE, Hyuck-Joo
Format Patent
LanguageEnglish
French
German
Published 09.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a compound represented by Formula 1 wherein A, B, L, X, and R1 to R6 are as described herein, or a pharmaceutically acceptable salt thereof, which serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of a disease associated with GLP-1 activity.
Bibliography:Application Number: EP20200895723